D
Guardant Health, Inc.
GH
$35.84
-$3.48-8.85%
D
Sell
8/15/2024Upgraded
Guardant Health, Inc. (GH) was upgraded to D- from E+ on 8/15/2024 due to an increase in the valuation index, total return index and volatility index.
Guardant Health, Inc. (GH) was upgraded to D- from E+ on 8/15/2024 due to an increase in the valuation index, total return index and volatility index.
E
Sell
8/4/2023Downgrade
Guardant Health, Inc. (GH) was downgraded to E+ from D- on 8/4/2023 due to a decline in the valuation index.
Guardant Health, Inc. (GH) was downgraded to E+ from D- on 8/4/2023 due to a decline in the valuation index.
D
Sell
5/10/2023Upgraded
Guardant Health, Inc. (GH) was upgraded to D- from E+ on 5/10/2023 due to an increase in the valuation index and growth index. Operating cash flow increased 17.97% from -$90.75M to -$74.44M, EBIT increased 11.42% from -$150.31M to -$133.16M, and earnings per share increased from -$1.365 to -$1.3007.
Guardant Health, Inc. (GH) was upgraded to D- from E+ on 5/10/2023 due to an increase in the valuation index and growth index. Operating cash flow increased 17.97% from -$90.75M to -$74.44M, EBIT increased 11.42% from -$150.31M to -$133.16M, and earnings per share increased from -$1.365 to -$1.3007.
E
Sell
3/14/2023Downgrade
Guardant Health, Inc. (GH) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
Guardant Health, Inc. (GH) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/24/2023Downgrade
Guardant Health, Inc. (GH) was downgraded to D- from D on 2/24/2023 due to a decline in the growth index, valuation index and solvency index. Debt to equity increased from 6.94 to 19.26, operating cash flow declined 16.11% from -$78.16M to -$90.75M, and EBIT declined 3.95% from -$144.6M to -$150.31M.
Guardant Health, Inc. (GH) was downgraded to D- from D on 2/24/2023 due to a decline in the growth index, valuation index and solvency index. Debt to equity increased from 6.94 to 19.26, operating cash flow declined 16.11% from -$78.16M to -$90.75M, and EBIT declined 3.95% from -$144.6M to -$150.31M.
D
Sell
2/9/2023Upgraded
Guardant Health, Inc. (GH) was upgraded to D from E+ on 02/09/2023.
Guardant Health, Inc. (GH) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Guardant Health, Inc. (GH) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
Guardant Health, Inc. (GH) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
11/7/2022Upgraded
Guardant Health, Inc. (GH) was upgraded to D from D- on 11/7/2022 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 30.17% from -$111.94M to -$78.16M, earnings per share increased from -$2.2483 to -$1.5837, and total revenue increased 7.57% from $109.14M to $117.4M.
Guardant Health, Inc. (GH) was upgraded to D from D- on 11/7/2022 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 30.17% from -$111.94M to -$78.16M, earnings per share increased from -$2.2483 to -$1.5837, and total revenue increased 7.57% from $109.14M to $117.4M.
D
Sell
10/21/2022Downgrade
Guardant Health, Inc. (GH) was downgraded to D- from D on 10/21/2022 due to a decline in the total return index.
Guardant Health, Inc. (GH) was downgraded to D- from D on 10/21/2022 due to a decline in the total return index.
D
Sell
10/6/2022Upgraded
Guardant Health, Inc. (GH) was upgraded to D from D- on 10/6/2022 due to an increase in the total return index and volatility index.
Guardant Health, Inc. (GH) was upgraded to D from D- on 10/6/2022 due to an increase in the total return index and volatility index.
D
Sell
5/31/2022Downgrade
Guardant Health, Inc. (GH) was downgraded to D- from D on 5/31/2022 due to a decline in the total return index and volatility index.
Guardant Health, Inc. (GH) was downgraded to D- from D on 5/31/2022 due to a decline in the total return index and volatility index.
D
Sell
5/16/2022Upgraded
Guardant Health, Inc. (GH) was upgraded to D from E+ on 05/16/2022.
Guardant Health, Inc. (GH) was upgraded to D from E+ on 05/16/2022.
E
Sell
5/13/2022Downgrade
Guardant Health, Inc. (GH) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.8939 to -$1.2099, debt to equity increased from 1.78 to 2.16, and EBIT declined 21.02% from -$98.21M to -$118.85M.
Guardant Health, Inc. (GH) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.8939 to -$1.2099, debt to equity increased from 1.78 to 2.16, and EBIT declined 21.02% from -$98.21M to -$118.85M.
D
Sell
5/4/2022Upgraded
Guardant Health, Inc. (GH) was upgraded to D from E+ on 05/04/2022.
Guardant Health, Inc. (GH) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Guardant Health, Inc. (GH) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Guardant Health, Inc. (GH) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Guardant Health, Inc. (GH) was upgraded to D from E+ on 04/21/2022.
Guardant Health, Inc. (GH) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Guardant Health, Inc. (GH) was downgraded to E+ from D on 4/20/2022 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 15.12 to 5.29, and debt to equity increased from 1.61 to 1.78.
Guardant Health, Inc. (GH) was downgraded to E+ from D on 4/20/2022 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 15.12 to 5.29, and debt to equity increased from 1.61 to 1.78.
D
Sell
11/23/2021Upgraded
Guardant Health, Inc. (GH) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Guardant Health, Inc. (GH) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Guardant Health, Inc. (GH) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and solvency index. The quick ratio declined from 19.1 to 15.12, and debt to equity increased from 1.45 to 1.61.
Guardant Health, Inc. (GH) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and solvency index. The quick ratio declined from 19.1 to 15.12, and debt to equity increased from 1.45 to 1.61.
D
Sell
5/17/2021Downgrade
Guardant Health, Inc. (GH) was downgraded to D from D+ on 5/17/2021 due to a major decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.63 to 1.34, and the quick ratio declined from 27.66 to 20.82.
Guardant Health, Inc. (GH) was downgraded to D from D+ on 5/17/2021 due to a major decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.63 to 1.34, and the quick ratio declined from 27.66 to 20.82.
D
Sell
3/5/2021Upgraded
Guardant Health, Inc. (GH) was upgraded to D+ from D on 3/5/2021 due to a substantial increase in the total return index, volatility index and solvency index. The quick ratio increased from 14.59 to 27.66.
Guardant Health, Inc. (GH) was upgraded to D+ from D on 3/5/2021 due to a substantial increase in the total return index, volatility index and solvency index. The quick ratio increased from 14.59 to 27.66.
D
Sell
5/1/2020Downgrade
Guardant Health, Inc. (GH) was downgraded to D from D+ on 5/1/2020 due to a noticeable decline in the efficiency index, total return index and solvency index. Net income declined 97.11% from -$12.79M to -$25.21M, and the quick ratio declined from 8.3 to 7.85.
Guardant Health, Inc. (GH) was downgraded to D from D+ on 5/1/2020 due to a noticeable decline in the efficiency index, total return index and solvency index. Net income declined 97.11% from -$12.79M to -$25.21M, and the quick ratio declined from 8.3 to 7.85.
D
Sell
2/11/2020Upgraded
Guardant Health, Inc. (GH) was upgraded to D+ from D on 2/11/2020 due to a noticeable increase in the total return index.
Guardant Health, Inc. (GH) was upgraded to D+ from D on 2/11/2020 due to a noticeable increase in the total return index.
D
Sell
10/29/2019Downgrade
Guardant Health, Inc. (GH) was downgraded to D from D+ on 10/29/2019 due to a large decline in the volatility index and valuation index.
Guardant Health, Inc. (GH) was downgraded to D from D+ on 10/29/2019 due to a large decline in the volatility index and valuation index.
D
Sell
12/31/2018None
Guardant Health, Inc. (GH) was downgraded to D+ from U on 12/31/2018.
Guardant Health, Inc. (GH) was downgraded to D+ from U on 12/31/2018.
NASDAQ
03/10/2025 4:00PM Eastern
Quotes delayed
